Výsledky vyhledávání - "Marie-Luise Memmer"

Excellent long-term survival of 170 patients with Waldenström’s macroglobulinemia treated in private oncology practices and a university hospital

Autor: H.-P. Feustel, Mathias Witzens-Harig, S. Fuxius, Jürgen Brust, Franz Mosthaf, Manfred Hensel, Christoph Plöger, A. D. Ho, J. Franz-Werner, Marie-Luise Memmer, Michael Rieger, A. Karcher, Dieter Schuster

Publikováno v: Annals of Hematology. 91:1923-1928

The purpose of this study was to compare treatment and outcome of patients with Waldenstrom’s macroglobulinemia (WM) in four private oncology practices (PP) and a university hospital (UH) in southwest Germany. We retrospectively reviewed the charts

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d997e2f8efa46bb7b7767f8e9c58c1d
https://doi.org/10.1007/s00277-012-1545-8

Zobrazit plný text záznamu

The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma

Autor: Sascha Dietrich, Mathias Witzens-Harig, Juliane Brandt, Marie-Luise Memmer, Silke Andresen, Anthony D. Ho

Publikováno v: Leukemialymphoma. 53(3)

In this study we investigated the quality of life (QoL) of long-term survivors with follicular lymphoma (FL) after high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) using two standardized questionnaires. Altogether, 124 patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012dbe32b0be2d7fbace0839fbba2768
https://pubmed.ncbi.nlm.nih.gov/21942939

Zobrazit plný text záznamu

Analysis of Prognostic Factors in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma and Skeletal Involvement: A Novel Simple Prognostic Score Identifies a Large Group of Low Risk Patients with an Excellent Prognosis

Autor: Marie-Luise Memmer, Mathias Witzens-Harig, Anthony D. Ho, Nicola Lehners

Publikováno v: Blood. 120:1590-1590

Abstract 1590 Background: Skeletal involvement (SI) is observed at low prevalence in patients with diffuse large B-cell lymphoma (DLBCL). Although extranodal lymphoma sites are generally regarded a risk factor, as reflected in the international progn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::083e4f88a894e42e972e70351db073ff
https://doi.org/10.1182/blood.v120.21.1590.1590

Zobrazit plný text záznamu

Quality of Life of Long Term Survivors with Follicular Lymphoma After High-Dose Chemotherapy with Autologous Stem Cell Transplantation and Conventional Chemotherapy

Autor: Marie-Luise Memmer, Mathias Witzens-Harig, Anthony D. Ho, Silke Andresen, Sascha Dietrich, Juliane Brandt

Publikováno v: Blood. 116:3808-3808

Abstract 3808 Introduction: High-dose chemotherapy (HDCT) followed by peripheral blood stem cell transplantation (PBSCT) is frequently applied in eligible patients with relapsed or refractory follicular lymphoma (FL). The toxicity of HDCT, however, m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c699668ff91d39f1079bb9eaae44563
https://doi.org/10.1182/blood.v116.21.3808.3808

Zobrazit plný text záznamu

A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma – the STORM trial

Autor: Marie Luise Memmer, Georg Hess, Martin Dreyling, Mathias Witzens-Harig

Publikováno v: BMC Cancer

Background The current standard treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma (DLBCL) primarily consists of intensified salvage therapy and, if the disease is chemo-sensitive, high dose therapy followed with aut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f93aa0647a4f0dcb6dc9d83b08fdf95

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání